DK1071418T3 - Nye behandlinger til nervelidelser - Google Patents

Nye behandlinger til nervelidelser

Info

Publication number
DK1071418T3
DK1071418T3 DK99918423T DK99918423T DK1071418T3 DK 1071418 T3 DK1071418 T3 DK 1071418T3 DK 99918423 T DK99918423 T DK 99918423T DK 99918423 T DK99918423 T DK 99918423T DK 1071418 T3 DK1071418 T3 DK 1071418T3
Authority
DK
Denmark
Prior art keywords
new treatments
nerve disorders
reboxetine
noradrenaline reuptake
new
Prior art date
Application number
DK99918423T
Other languages
Danish (da)
English (en)
Inventor
John Michael Mccall
Duncan Paul Taylor
Voigtlander Philip F Von
Erik Ho Fong Wong
Adriana Dubini
Original Assignee
Pharmacia Italia Spa
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa, Upjohn Co filed Critical Pharmacia Italia Spa
Application granted granted Critical
Publication of DK1071418T3 publication Critical patent/DK1071418T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Mobile Radio Communication Systems (AREA)
DK99918423T 1998-04-13 1999-04-02 Nye behandlinger til nervelidelser DK1071418T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8163298P 1998-04-13 1998-04-13
IT98MI000870 IT1305322B1 (it) 1998-04-23 1998-04-23 Uso di reboxetina per il trattamento di disturbi nervosi
US8503398P 1998-05-11 1998-05-11
EP99918423A EP1071418B1 (fr) 1998-04-13 1999-04-02 Nouveaux traitements pour troubles nerveux

Publications (1)

Publication Number Publication Date
DK1071418T3 true DK1071418T3 (da) 2005-01-03

Family

ID=11379879

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99918423T DK1071418T3 (da) 1998-04-13 1999-04-02 Nye behandlinger til nervelidelser

Country Status (25)

Country Link
US (1) US6391876B1 (fr)
EP (1) EP1071418B1 (fr)
JP (1) JP2002511408A (fr)
KR (1) KR100555279B1 (fr)
CN (1) CN1197569C (fr)
AT (1) ATE277617T1 (fr)
AU (1) AU755612B2 (fr)
BR (1) BR9909476A (fr)
CA (1) CA2320722A1 (fr)
DE (1) DE69920679T2 (fr)
DK (1) DK1071418T3 (fr)
EA (1) EA003546B1 (fr)
ES (1) ES2228035T3 (fr)
HU (1) HUP0101748A3 (fr)
IL (1) IL138887A0 (fr)
IT (1) IT1305322B1 (fr)
NO (1) NO20005131L (fr)
NZ (1) NZ507693A (fr)
PL (1) PL194039B1 (fr)
PT (1) PT1071418E (fr)
SI (1) SI1071418T1 (fr)
SK (1) SK14482000A3 (fr)
TR (1) TR200002970T2 (fr)
WO (1) WO1999052518A2 (fr)
ZA (1) ZA200004480B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500827B2 (en) * 1998-05-08 2002-12-31 Pharmacia & Upjohn Company Drug combinations
ES2242175T3 (es) 1999-07-01 2005-11-01 PHARMACIA & UPJOHN COMPANY LLC (s,s)-reboxetina para tratar la fibromialgia y otros trastornos somatoformes.
EP1459749B1 (fr) * 1999-07-01 2005-10-05 Pharmacia & Upjohn Company LLC (S,S)-réboxétine pour traiter l'incontinence
AU2002217757A1 (en) * 2000-11-15 2002-05-27 Eli Lilly And Company Treatment of anxiety disorders
CN101298440A (zh) * 2002-06-17 2008-11-05 辉瑞意大利公司 瑞波西汀的药物盐
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB8419683D0 (en) 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane
GB2167407B (en) * 1984-11-22 1988-05-11 Erba Farmitalia Enantiomers of phenoxy derivatives of benzyl morpholine and salts thereof
EP0919234A3 (fr) 1997-10-17 1999-08-25 Eli Lilly And Company Potentialisation d'un médicament par la moxonidine

Also Published As

Publication number Publication date
NO20005131D0 (no) 2000-10-12
IL138887A0 (en) 2001-11-25
SI1071418T1 (en) 2005-04-30
HUP0101748A3 (en) 2001-12-28
HUP0101748A2 (hu) 2001-11-28
IT1305322B1 (it) 2001-05-04
CA2320722A1 (fr) 1999-10-21
CN1293569A (zh) 2001-05-02
ES2228035T3 (es) 2005-04-01
PT1071418E (pt) 2004-12-31
WO1999052518A2 (fr) 1999-10-21
CN1197569C (zh) 2005-04-20
NO20005131L (no) 2000-10-12
PL194039B1 (pl) 2007-04-30
KR100555279B1 (ko) 2006-03-03
KR20010042641A (ko) 2001-05-25
ZA200004480B (en) 2002-04-24
JP2002511408A (ja) 2002-04-16
EP1071418A2 (fr) 2001-01-31
EA200001058A1 (ru) 2001-04-23
PL346294A1 (en) 2002-01-28
SK14482000A3 (sk) 2001-08-06
DE69920679T2 (de) 2006-03-02
US6391876B1 (en) 2002-05-21
ITMI980870A1 (it) 1999-10-23
BR9909476A (pt) 2000-12-19
AU755612B2 (en) 2002-12-19
TR200002970T2 (tr) 2001-01-22
DE69920679D1 (de) 2004-11-04
AU3635199A (en) 1999-11-01
ATE277617T1 (de) 2004-10-15
EP1071418B1 (fr) 2004-09-29
WO1999052518A3 (fr) 1999-12-02
NZ507693A (en) 2003-08-29
EA003546B1 (ru) 2003-06-26

Similar Documents

Publication Publication Date Title
UA43385C2 (uk) Спосіб лікування синдрому дефіциту уваги/гіперактивності
DK1071418T3 (da) Nye behandlinger til nervelidelser
BRPI0407256A (pt) Utilização do enantiÈmero (1s,2r) do milnacipran para a preparação de um medicamento
ES2166110T3 (es) Agonistas no alostericos de gabaa para tratar trastornos del sueño.
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
MY134110A (en) Combinations of reboxetine and neuroleptic agents
ATE329588T1 (de) Verwendung von sibutramin zur behandlung von von organischen störungen verursachten zns- erkrankungen
IL201038A (en) Use of Millanasipran Enantiomer (s1, r2) to prepare a drug
AR058239A1 (es) Metodos para tratar trastornos de ansiedad
DE50313386D1 (de) Mittelwalze eines Kalanders mit einer Tilgeranordnung
NO20021035L (no) Fremgangsmåter for anvendelse av rasktvirkende selective serotonin gjenopptakningsinhibitorer for behandling av seksuelldysfunksjon
AR021155A1 (es) Tratamiento de desordenes neuroticos
MY136367A (en) Treatment of cognitive failure
PT1075264E (pt) Novas combinacoes farmacologicas de reboxetina e pindolol
BR0115301A (pt) Uso de um inibidor seletivo da recaptação de norepinefrina
DK1152757T3 (da) MMP-inhibitorer i bindevævsblödhed
PT1282414E (pt) Compostos derivados de felbamato para o tratamento da dor neuropatica
DK1332229T3 (da) Fremgangsmåde til screening af midler til at behandle overvægt
ECSP992873A (es) Metodo para tratar desordenes compulsivos, obsesivos, desordenes somatoformes, desordenes disociativos, desordenes al comer, desordenes de control de impulso, y autismo (caso cn0823)
ATE486880T1 (de) Neue stromelysin inhibitoren
ES1040148U (es) Criba de levas
ATE481167T1 (de) Katalysator für die hydrierung von ungesättigten kohlenwasserstoffen